Following this logic, we hypothesized that if the TRPM2 level was increased by global cerebral ischemia-induced cell death cascades, regulation of TRPM2 as a potential target for preventing ischemia-induced injury could ameliorate a diverse number of cerebral pathologies associated with ischemia. The gene discussed is TRPM2; the disease is brain ischemia.